Diagnosing Alzheimer’s disease has long relied on tests that are expensive, hard to access or uncomfortable. Researchers led by Professor Thomas Karikari at the University of Pittsburgh have developed a blood test that measures a specific marker of brain damage linked to Alzheimer’s, bringing simpler testing a step closer.
Why diagnosing Alzheimer’s is difficult
Alzheimer’s is the most common cause of dementia. Doctors look for three key signs: a buildup of amyloid protein, a buildup of tau protein, and damage to nerve cells in the brain. Confirming these usually requires:
- Brain imaging, such as PET scans, which are expensive and not widely available
- A lumbar puncture (spinal tap) to test the fluid around the brain and spinal cord, which some people find uncomfortable
Many patients face long waits or can’t access these tests at all, which delays diagnosis.
What’s different about this test
Existing blood tests can detect abnormal levels of amyloid and some forms of tau. But measuring nerve cell damage specific to the brain has been harder, because some markers in the blood can also come from elsewhere in the body.
The Pittsburgh team developed an antibody-based test that detects a form of tau called brain-derived tau, which comes specifically from the brain. Their findings were published in the journal Brain.
What the researchers found
Testing samples from about 600 people at different stages of Alzheimer’s, the researchers found that:
- Blood levels matched spinal fluid levels. Brain-derived tau in the blood tracked closely with tau levels in spinal fluid.
- It distinguished Alzheimer’s from other conditions. The test could tell Alzheimer’s apart from other neurodegenerative diseases.
- It reflected brain changes. Levels were strongly linked to the amount of amyloid plaques and tau tangles found in brain tissue examined after death.
Why a blood test matters
A blood test is cheaper, safer and easier to give than imaging or a spinal tap. It could help doctors diagnose Alzheimer’s earlier and with more confidence, select the right people for clinical trials, and monitor how the disease changes over time. Earlier diagnosis also matters more now that some treatments target the disease in its early stages.
Simpler testing could also widen access for people in rural or underserved areas, where specialist scans may be hours away.
Keep in mind
Blood tests for Alzheimer’s are still being refined, and results need to be interpreted by a specialist alongside a full evaluation of memory and thinking. A blood test alone isn’t meant to diagnose dementia. Larger studies in more diverse groups of people are needed to confirm how well this test performs in everyday practice.
What this means for you
- Don’t ignore memory changes. If you or a loved one notice worsening memory, confusion or trouble with everyday tasks, see a doctor.
- Ask about evaluation options. A doctor or memory clinic can explain which tests are available and appropriate.
- Remember other causes. Memory problems can stem from treatable issues like vitamin deficiencies, thyroid problems, depression or medication side effects.
- Protect your brain. Regular exercise, good sleep, social connection and managing blood pressure and blood sugar all support brain health.
- Consider research. If you’re interested, ask about joining Alzheimer’s research studies, which help move new tests and treatments forward.
The bottom line
A new blood test that measures brain-derived tau may help diagnose Alzheimer’s more simply and specifically. It’s still being studied, but it brings easier, earlier diagnosis closer.
This article is for general information and isn’t medical advice. Talk with your healthcare provider about your individual needs.
